AR090095A1 - Preparacion farmaceutica que comprende hormona estimulante del foliculo recombinante - Google Patents
Preparacion farmaceutica que comprende hormona estimulante del foliculo recombinanteInfo
- Publication number
- AR090095A1 AR090095A1 ARP120101991A ARP120101991A AR090095A1 AR 090095 A1 AR090095 A1 AR 090095A1 AR P120101991 A ARP120101991 A AR P120101991A AR P120101991 A ARP120101991 A AR P120101991A AR 090095 A1 AR090095 A1 AR 090095A1
- Authority
- AR
- Argentina
- Prior art keywords
- stimulating hormone
- folicle
- recombinant
- pharmaceutical preparation
- includes stimulating
- Prior art date
Links
- 229940088597 hormone Drugs 0.000 title 1
- 239000005556 hormone Substances 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 230000004936 stimulating effect Effects 0.000 title 1
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 abstract 2
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 abstract 2
- 229940028334 follicle stimulating hormone Drugs 0.000 abstract 2
- 150000004676 glycans Chemical group 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Preparaciones que incluyen HEF (Hormona estimulante del folículo), por ejemplo HEF recombinada, en donde 17% a 23% de las estructuras glicano sialiladas son estructuras glicano tetra-sialiladas. Hormona estimulante del folículo. Método de tratamiento.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11168816 | 2011-06-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR090095A1 true AR090095A1 (es) | 2014-10-22 |
Family
ID=46397316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP120101991A AR090095A1 (es) | 2011-06-06 | 2012-06-06 | Preparacion farmaceutica que comprende hormona estimulante del foliculo recombinante |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2717904A1 (es) |
AR (1) | AR090095A1 (es) |
WO (1) | WO2012168680A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI488640B (zh) | 2008-04-16 | 2015-06-21 | Ferring Int Ct Sa | 藥學製劑 |
CN113198005B (zh) * | 2015-09-17 | 2024-09-06 | 广州汉腾生物科技有限公司 | 具有提高的稳定性的哺乳动物促卵泡激素组合物 |
MD3675894T2 (ro) | 2017-09-01 | 2022-03-31 | Ferring Bv | Compoziție pentru stimularea ovariană controlată |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1621549A3 (en) * | 2001-10-22 | 2006-03-01 | Applied Research Systems ARS Holding N.V. | Compositions of fsh with high sialylation degree and their use for the preparation of medicinaments |
CA2557725C (en) * | 2004-02-13 | 2015-06-30 | Glycotope Gmbh | Highly active glycoproteins-process conditions and an efficient method for their production |
TWI488640B (zh) | 2008-04-16 | 2015-06-21 | Ferring Int Ct Sa | 藥學製劑 |
TWI604850B (zh) * | 2009-10-05 | 2017-11-11 | 菲瑞茵國際中心股份有限公司 | 藥學製劑 |
WO2012016576A1 (en) | 2010-08-04 | 2012-02-09 | Glycotope Gmbh | Improved recombinant human follicle-stimulating hormone |
-
2012
- 2012-06-06 EP EP12730594.4A patent/EP2717904A1/en not_active Withdrawn
- 2012-06-06 WO PCT/GB2012/000491 patent/WO2012168680A1/en active Application Filing
- 2012-06-06 AR ARP120101991A patent/AR090095A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2012168680A1 (en) | 2012-12-13 |
EP2717904A1 (en) | 2014-04-16 |
WO2012168680A8 (en) | 2014-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JO3357B1 (ar) | مركبات إيميدازوبيروليدينون | |
PH12016501966A1 (en) | Compounds and compositions as toll-like receptor 7 agonists | |
MX2017016376A (es) | Derivado de piperidina y metodo de preparacion y uso farmaceutico del mismo. | |
CR20160564A (es) | Dinucleótidos cíclicos como moduladores de sting | |
NZ629996A (en) | 2’- substituted carba-nucleoside analogs for antiviral treatment | |
MY188139A (en) | Sodium channel modulators for the treatment of pain | |
UY34101A (es) | Proteínas de unión a antígeno | |
BR112017005202A2 (pt) | anticorpos anti-met e composições | |
CY1119957T1 (el) | Θεραπεια νοσηματων με τη χρηση ανοχογονου φαρμακευτικου παρασκευασματος | |
DOP2014000059A (es) | Derivados de estra1,3,5(10),16tetraen3carboxamida, procedimientos para su preparación, preparados farmacéuticos que los contienen, así como su uso para la preparación de medicamentos | |
UY35906A (es) | Novedosos derivados de bencimidazol como ligandos de ep4 | |
MX2018000264A (es) | Formulaciones topicas de diacereina de rheina y sus usos. | |
EA201690191A1 (ru) | Фармацевтическая композиция для замедленного высвобождения ланреотида | |
EA201792571A1 (ru) | Терапевтическое применение l-4-хлорокинуренина | |
MX2017013564A (es) | Formulaciones de glucopiranosil lipido a y alérgenos de cacahuete para administración sublingual. | |
PH12017501735A1 (en) | Novel heterocyclic compound, method for preparing the same, and pharmaceutical composition comprising the same | |
CL2014003443A1 (es) | Compuestos derivados de n-[4-(quinolin-4-iloxi)ciclohexil(metil)](hetero)aril-carboxamidas; su metodo de produccion; compuestos intermediarios; producto medicinal que contiene al compuesto, util para el tratamiento y/o prevencion de enfermedades hiperproliferativas, las cuales son dependientes del receptor de androgenos. | |
PH12014502065A1 (en) | Vesicular formulations | |
AR090095A1 (es) | Preparacion farmaceutica que comprende hormona estimulante del foliculo recombinante | |
WO2015057836A3 (en) | Bone anabolic parathyroid hormone and parathyroid hormone related-protein analogs | |
MX364528B (es) | Witanólidos útiles para el tratamiento de enfermedades neurodegenerativas. | |
EA201270176A1 (ru) | Производные тазаротена | |
MX2016005645A (es) | Composicion farmaceutica topica de acitretina. | |
IN2013MU03118A (es) | ||
MX2015016283A (es) | METODOS PARA TRATAR AFECCIONES INFLAMATORIAS UTILIZANDO S-[4-(3-FLUORO-3-METILBUTIRILOXI) BUT-2-INIL] 6A, 9A-DIFLUORO-17A- (FURAN-2-IL) CARBONILOXI-11ß-HIDROXI-16A - METIL-3-OXOANDROSTA-1,4-DIEN-17ß - CARBOTIOATO. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |